Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Starfront Observatories: A haven for distant stargazers - 2Geomagnetic storm grounds launch of Mars space weather satellites
- 3Discovery of massive spider's web in Greece reveals unexpected behavior
- 4Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
- 5Manual for Conservative SUVs For Seniors
- Don't miss these five impressive spots in Bangkok
- Become the best at Discussion: 6 Procedures for Progress
- Mississippi Insight for Jan. 11, 2026
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Bomb blast in packed Nigerian mosque kills five
- Equality requires universal draft, participation in economy and workforce, MK Liberman says
